Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Other Operating Expenses (2018 - 2025)

TELA Bio has reported Other Operating Expenses over the past 8 years, most recently at $12.4 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $12.4 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $54.9 million (up 624.92% YoY), and the annual figure for FY2025 was $54.9 million, up 624.92%.
  • Other Operating Expenses for Q4 2025 was $12.4 million at TELA Bio, down from $13.1 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for TELA hit a ceiling of $17.2 million in Q4 2023 and a floor of -$20000.0 in Q2 2024.
  • Median Other Operating Expenses over the past 5 years was $11.4 million (2022), compared with a mean of $10.8 million.
  • Biggest five-year swings in Other Operating Expenses: crashed 100.14% in 2024 and later skyrocketed 73595.0% in 2025.
  • TELA Bio's Other Operating Expenses stood at $8.3 million in 2021, then soared by 40.11% to $11.6 million in 2022, then soared by 47.37% to $17.2 million in 2023, then crashed by 100.12% to -$20000.0 in 2024, then soared by 62130.0% to $12.4 million in 2025.
  • The last three reported values for Other Operating Expenses were $12.4 million (Q4 2025), $13.1 million (Q3 2025), and $14.7 million (Q2 2025) per Business Quant data.